Stockreport

NewAmsterdam Pharma to Present at the Stifel 2025 Virtual Cardiometabolic Forum [Yahoo! Finance]

NewAmsterdam Pharma Company N.V. - Ordinary Shares  (NAMS) 
PDF Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patient [Read more]